Clinical Trial - Trial jRCT2031230117
Access comprehensive clinical trial information for jRCT2031230117 through Pure Global AI's free database. This phase not specified trial is sponsored by ID Pharma Co., Ltd. and is currently Recruiting. The study focuses on Osteoporosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
jRCT2031230117
Recruiting
Trial Details
Japan Registry Clinical Trial • jRCT2031230117
Untitled Trial
A multi center, randomized, double blind, parallel group, phase III study to evaluate efficacy, safety and immunogenicity of Lupins Denosumab in comparison with Prolia in postmenopausal women with osteoporosis.
Study Focus
Interventional
Sponsor & Location
ID Pharma Co., Ltd.
India
Timeline & Enrollment
N/A
N/A
N/A
ICD-10 Classifications
Osteoporosis, unspecified
Other osteoporosis
Idiopathic osteoporosis
Osteoporosis in diseases classified elsewhere
Postmenopausal osteoporosis
Data Source
Japan Registry Clinical Trial
jRCT2031230117
Non-Device Trial